Timegadine
Alternative Names: SR 1368Latest Information Update: 16 Feb 1995
At a glance
- Originator LEO Pharma
- Class Antirheumatics; Nonsteroidal anti-inflammatories
- Mechanism of Action Lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders
Most Recent Events
- 16 Feb 1995 Discontinued-III for Rheumatic disorders (Unknown route)